Sheesh! That would be a game changer if it works. I imagine someone like resmed would need to buy it to get all the approvals and studies to get credibility done? In which case not so much of a threat as standard evolution of the products??
I've held RMD previously but took a profit when it went unexpectedly high. I suspect it's a good company for a long term hold but probably best to wait for some short term bad news to enter (like now). However I'm wondering if the final wash up from the failed study will take a while to work through to affect revenue and I'm inclined to review in 6 months and see how it looks. Any thoughts on whether there have been sales over the past year based on the expectation that the failed study should have been a success?
GLTH,
cheers,
Pb
RMD Price at posting:
$7.61 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)